These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 24778572)
1. Sarcoma immunotherapy: past approaches and future directions. D'Angelo SP; Tap WD; Schwartz GK; Carvajal RD Sarcoma; 2014; 2014():391967. PubMed ID: 24778572 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of Childhood Sarcomas. Roberts SS; Chou AJ; Cheung NK Front Oncol; 2015; 5():181. PubMed ID: 26301204 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic approaches to sarcoma. Burgess M; Tawbi H Curr Treat Options Oncol; 2015 Jun; 16(6):26. PubMed ID: 25975445 [TBL] [Abstract][Full Text] [Related]
4. Manipulating the Immune System With Checkpoint Inhibitors for Patients With Metastatic Sarcoma. D'Angelo SP Am Soc Clin Oncol Educ Book; 2016; 35():e558-64. PubMed ID: 27249767 [TBL] [Abstract][Full Text] [Related]
5. The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers. Liang J; Chen D; Chen L; She X; Zhang H; Xiao Y Future Oncol; 2020 Jun; 16(17):1211-1223. PubMed ID: 32396026 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. Nathenson MJ; Conley AP; Sausville E Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for sarcomas. Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603 [TBL] [Abstract][Full Text] [Related]
8. Emerging Targeted and Immune-Based Therapies in Sarcoma. Pollack SM; Ingham M; Spraker MB; Schwartz GK J Clin Oncol; 2018 Jan; 36(2):125-135. PubMed ID: 29220291 [TBL] [Abstract][Full Text] [Related]
12. Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit? Chew HY; Chan V; Simpson F; Dolcetti R Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207697 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in Sarcoma: Future Horizons. Burgess M; Gorantla V; Weiss K; Tawbi H Curr Oncol Rep; 2015 Nov; 17(11):52. PubMed ID: 26423769 [TBL] [Abstract][Full Text] [Related]
14. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional. Borgatti A; Dickerson EB; Lawrence J Vet Comp Oncol; 2020 Mar; 18(1):9-24. PubMed ID: 31749286 [TBL] [Abstract][Full Text] [Related]
15. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials. Zhu MMT; Shenasa E; Nielsen TO Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422 [TBL] [Abstract][Full Text] [Related]
16. From vision to reality: deploying the immune system for treatment of sarcoma. Wilky BA; Goldberg JM Discov Med; 2017 Jan; 23(124):61-74. PubMed ID: 28245428 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic strategies for sarcoma: current perspectives. Li X; Wang G; Cai Z; Sun W Am J Transl Res; 2020; 12(12):7693-7701. PubMed ID: 33437354 [TBL] [Abstract][Full Text] [Related]
18. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy? Atherton MJ; Lenz JA; Mason NJ Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517 [TBL] [Abstract][Full Text] [Related]
19. Advances in immune checkpoint inhibitors for bone sarcoma therapy. Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z J Bone Oncol; 2019 Apr; 15():100221. PubMed ID: 30775238 [TBL] [Abstract][Full Text] [Related]
20. Is immunotherapy in the future of therapeutic management of sarcomas? Clemente O; Ottaiano A; Di Lorenzo G; Bracigliano A; Lamia S; Cannella L; Pizzolorusso A; Di Marzo M; Santorsola M; De Chiara A; Fazioli F; Tafuto S J Transl Med; 2021 Apr; 19(1):173. PubMed ID: 33902630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]